Your body relies on the KDR gene to help blood vessels form, grow, and repair by responding to signals that guide the cells lining those vessels. If this gene does not work properly, blood vessel growth and maintenance may be affected, which can contribute to problems such as pulmonary arterial hypertension in some people. Many variants in this gene have little effect, while a smaller number can change how strongly these blood vessel signals work.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or regulating processes in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. To explore this topic in greater depth, you can read more in the LearnHub.
Overview
KDRGene function
What if the gene works
The KDR gene helps cells lining blood vessels respond to growth signals. This supports blood vessel formation, repair, and normal blood flow.
Risk
What if the gene does not work
Pathogenic variants in the KDR gene can cause pulmonary arterial hypertension (high blood pressure in the lungs). Milder or more severe variants may affect when it starts and how pronounced it becomes.
Treatment
What does that mean for your treatment
No KDR-specific treatment or management approach is currently established for people with a pathogenic variant in the KDR gene. The KDR gene is being studied and targeted in cancer care because it helps control blood vessel growth, but this does not currently translate into a guideline-based drug choice for germline KDR-related conditions.
Conditions associated with KDR
Gene function
What if the gene works
Your blood vessels depend on the KDR gene to respond to growth signals in a controlled way. Its protein sits on the surface of cells lining blood vessels and helps them read messages that guide vessel growth, shape, and upkeep. This supports healthy circulation from early development through everyday tissue repair.
Its protein sits on the cell surface and receives VEGF, a growth signal for blood vessels, from nearby tissues. It passes that message into cells lining blood vessels so they can respond in an organized way.
Signals through the KDR gene help control how new blood vessels grow and branch. This supports normal development and helps tissues build the blood supply they need.
The KDR gene helps cells lining blood vessels move toward places where new vessels are forming. This helps shape a connected network that can deliver oxygen and nutrients.
KDR signaling supports the growth and everyday maintenance of cells that form the inner lining of blood vessels. This helps keep vessel walls stable as tissues grow and renew.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and form part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KDR gene can change the receptor’s shape, stability, or signaling activity, so cells receive weaker or less consistent growth signals. This is how variants influence the KDR gene's function: milder changes may partly reduce signaling, while more severe variants can prevent the protein from folding properly, reaching the cell surface, or working at all.
How variants are linked to conditions
Rare disease-causing variants in the KDR gene are linked to pulmonary arterial hypertension, a condition involving high pressure in the blood vessels of the lungs. Some people with KDR gene variants linked to pulmonary arterial hypertension also have a reduced ability for the lungs to move oxygen into the blood and changes on chest scans. Symptoms and severity can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect normal human diversity. In many genes, a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the KDR gene. Risk can vary depending on the exact gene change and the health condition involved, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of KDR variants
For families looking at how KDR gene variants are inherited, the main recognized pattern is autosomal dominant. This means one changed copy of the KDR gene can be enough to increase the chance of a KDR-related condition. If a parent carries the variant, each child has a 50% chance of inheriting it. People in the same family can be affected differently, so inheriting the variant does not always mean the same signs or symptoms will appear.
What does my KDR result mean for my family?
For KDR, the family impact depends on which health condition the result is linked to, because this gene has been connected to more than one inherited condition. In families where a harmful KDR change causes disease, it is often passed in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. That means family members may want to talk with their doctor or a genetic counselor about whether the result could be relevant for them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the KDR gene, genetic testing uses DNA from blood, saliva, or a cheek swab. A test for KDR gene variants reads the gene's code and looks for changes that may help explain a health condition or support a diagnosis. Results may be benign, uncertain, or pathogenic.
When should I consider getting a genetic test?
There isn't yet a broadly established, KDR-specific clinical reason for testing in most people. Testing decisions are usually based on personal and family history, especially unexplained lung or blood vessel problems, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they explain varies with the condition and the kind of variant found. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic finding may offer a clear answer. In areas such as response to medications, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one of several factors, along with age, kidney and liver function, and other medicines, that shape medication response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. To learn more about this topic, visit the LearnHub.
Drugs influenced by the KDR gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, treatment response, or medicine safety are best discussed with your doctor. Research on the KDR gene has looked at whether it may affect response or side effects with some cancer drugs that block blood vessel growth, but this is not used routinely in everyday care.
History
In the early 1990s, researchers identified the KDR gene while tracing how blood vessels form and respond to growth signals. It soon became a landmark in vascular biology because it helped connect earlier lab findings on vessel growth with a specific inherited instruction in cells. First described in the scientific literature as part of early genetics, KDR was also known in some studies as VEGFR2 or FLK1, reflecting parallel work in different research groups. From these first observations, research expanded steadily into cancer, eye disease, and cardiovascular science. The gene became more broadly recognized as drugs targeting the same pathway entered routine medical care. This history helped turn blood vessel growth from a basic science question into a major area of modern treatment research.